Akebia Therapeutics (AKBA) Net Margin (QoQ) (2017 - 2026)
Akebia Therapeutics (AKBA) Net Margin (QoQ) (2017 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 44.16 Bn | 43.20 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.86 Bn | 40.20 Bn | 2.15 Bn |
| 3 | Zoetis | 32.53 Bn | 30.86 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.84 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.34 Bn | 19.68 Bn | 683.80 Mn |
| 6 | Viatris | 18.89 Bn | 18.00 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.54 Bn | 15.15 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.95 Bn | 11.42 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - |
| 10 | Akebia Therapeutics | 253.97 Mn | 98.42 Mn | 38.70 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -122.00 |
| Mar 31, 2026 | 434.00 |
| Dec 31, 2025 | -2,217.00 |
| Sep 30, 2025 | 52.00 |
| Jun 30, 2025 | -1,026.00 |
| Mar 31, 2025 | 5,970.00 |
| Dec 31, 2024 | 450.00 |
| Sep 30, 2024 | -3,388.00 |
| Jun 30, 2024 | 3,550.00 |
| Mar 31, 2024 | -5,625.00 |
| Dec 31, 2023 | 3,555.00 |
| Sep 30, 2023 | -1,464.00 |
| Jun 30, 2023 | 4,736.00 |
| Mar 31, 2023 | -5,979.00 |
| Dec 31, 2022 | 10,366.00 |
| Sep 30, 2022 | -13,435.00 |
| Jun 30, 2022 | 8.36 Mn |
| Mar 31, 2022 | -8.36 Mn |
| Dec 31, 2021 | 16,693.00 |
| Sep 30, 2021 | 3,481.00 |